Perrigo (PRGO) Capital Expenditures Growth (3y) (2016 - 2026)
Perrigo (PRGO) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 75.58% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.56% |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -15.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -15.90% |
| Dec 31, 2025 | -32.23% |
| Sep 27, 2025 | 36.98% |
| Jun 28, 2025 | -12.23% |
| Mar 29, 2025 | 7.90% |
| Dec 31, 2024 | -22.66% |
| Sep 28, 2024 | 130.95% |
| Jun 29, 2024 | 7.28% |
| Mar 30, 2024 | -17.93% |
| Dec 31, 2023 | -41.92% |
| Sep 30, 2023 | 190.29% |
| Jul 1, 2023 | 180.20% |
| Apr 1, 2023 | -11.79% |
| Dec 31, 2022 | 13.56% |
| Oct 1, 2022 | -45.47% |
| Jul 2, 2022 | -5.45% |
| Apr 2, 2022 | -1.28% |
| Dec 31, 2021 | 207.61% |
| Oct 2, 2021 | 85.66% |
| Jul 3, 2021 | 4.94% |